peritoneal surface oncology (psogi) modified delphi process (Surface Oncology)
90
Structured Review
Surface Oncology
peritoneal surface oncology (psogi) modified delphi process
Peritoneal Surface Oncology (Psogi) Modified Delphi Process, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/delphi+process/peritoneal+surface+oncology/pm39979656-605-30-24
Average 90 stars, based on 1 article reviews
Peritoneal Surface Oncology (Psogi) Modified Delphi Process, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/delphi+process/peritoneal+surface+oncology/pm39979656-605-30-24
Average 90 stars, based on 1 article reviews
peritoneal surface oncology (psogi) modified delphi process - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies. Article Snippet: Background.. Malignant gastrointestinal obstruction (MGIO), a frequent complication of peritoneal surface malignancies (PSM), often portends a poor prognosis.. The lack of high-quality evidence on optimal management strategies necessitated a national consensus to address this clinical problem. Article Title: Consensus guideline for the management of peritoneal mesothelioma. Article Snippet: Alignment with national and international guidelines: The National Comprehensive Cancer Network and Article Title: Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Article Snippet: Elizabeth L. Godfrey MD | Forest Mahoney BS | Varun V. Bansal MBBS | David G. Su MD | David N. Hanna MD | Felipe Lopez-Ramirez MD | Ekaterina Baron MD | Kiran K. Turaga MD, MPH | Al B. Benson III MD | Namrata Setia MD | Joshua H. Winer MD | Craig G. Gunderson MD | Rupen Shah MD | Deepa R. Magge MD | Ian Solsky MD, MPH | Cathy Eng MD | Oliver S. Eng MD | Ardaman Shergill MD, MSPH | John Paul Shen MD | Joseph Misdraji MD | Michael B. Foote MD | Wenyi Luo MD | Peritoneal Surface Malignancies Consortium Group Article Title: Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Article Snippet: Yale School of Medicine, New Haven, Connecticut, USA Emory University, Atlanta, Georgia, USA Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA University of California San Francisco, San Francisco, California, USA Moffitt Cancer Center, Tampa, Florida, USA Mayo Clinic, Rochester, Minnesota, USA University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA Cedars-Sinai Medical Center, Los Angeles, California, USA Article Title: Consensus guideline for the management of colorectal cancer with peritoneal metastases. Article Snippet: Kurt S. Schultz MD | Varun V. Bansal MBBS | Michael M. Wach MD | Neal Bhutiani MD, PhD | Frederick A. Godley IV MD, MBA | Jaeyun (Jane) Wang MD | Muhammad Talha Waheed MBBS | Joanna T. Buchheit MD | Emily Papai MD | Susan Campbell MD | Lauren E. Schleimer MD | David G. Su MD | Kiran K. Turaga MD, MPH | Craig G. Gunderson MD | Michael G. White MD, MSc | Abhineet Uppal MD | Kanwal P. S. Raghav MBBS, MD | Daniel M. Labow MD, MSc | Umut Sarpel MD, MSc | Ardaman P. Shergill MD | John Paul Shen MD | Cathy Eng MD | Michael B. Foote MD | Joel M. Baumgartner MD | Peritoneal Surface Malignancies Consortium Group Article Title: Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases. Article Snippet: Background.. The peritoneum is a common site of metastases from colorectal cancer (CRC), yet controversy exists regarding optimal treatment strategies.. These guidelines describe the results of a national consensus addressing the management of CRC with peritoneal metastases (CRC-PM). Article Title: Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Article Snippet: Elizabeth L. Godfrey, MD1, Forest Mahoney, BS2, Varun V. Bansal, MBBS1, David G. Su, MD1, David N. Hanna, MD3, Felipe Lopez‐Ramirez, MD4, Ekaterina Baron, MD5, Kiran K. Turaga, MD, MPH, FACS1, Al B. Benson III, MD6, James Cusack, MD7, Joshua H. Winer, MD8, Craig G. Gunderson, MD1,9,18, Joseph Misdraji, MD10, Rupen Shah, MD11, Deepa R. Magge, MD3, Ian Solsky, MD, MPH12, Cathy Eng, MD13, Oliver S. Eng, MD14, Ardaman Shergill, MD, MSPH15, John Paul Shen, MD16, Michael B. Foote, MD17, and Peritoneal Surface Malignancies (PSM) Consortium Group Modification:Article Title: ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases. Article Snippet: Background.. Colorectal peritoneal metastases (CRPM) represent a significant treatment challenge for patients with colorectal cancer that significantly impact quality of life and limit survival.. Patients and Methods. |